Taking this into account, and considering the fact that there are no SERT binding studies done in patients with epilepsy, it could be difficult to predict the directionality of alterations in SERT binding in patients with epilepsy and comorbid depression. This evidence concerns the gene SLC6A4 and major depressive disorder.